Cambridge Health Alliance

Name :

Cambridge Health Alliance

Address  :

1493 Cambridge Street

Town  :

Cambridge

State  :

Massachusetts

Country  :

USA

Post Code:

02139

Phone  :

617 665 2300

Web URL  :


Description

Cambridge Health Alliance CHA is an integrated health system serving Cambridge Somerville and Bostons metronorth communities With three hospital campuses an extensive primary care network and an employed physician model CHA provides highquality culturally competent care to a large diverse patient population In addition its health plan Network Health provides comprehensive health coverage to more than 160000 Massachusetts residents

Mission To improve the health of our communities

Vision To be the premier academic public health care system
in the nation

Values Community Integrity Respect Compassion Learning Excellence CIRCLE


History

Our History
CHA was formed in 1996 when two Massachusetts hospitals Cambridge Hospital and Somerville Hospital joined together and along with their community health centers began operating under one hospital license As a combined entity the system was better able to meet the needs of its patients and fulfill its shared community health mission

In 1997 CHA created Network Health to provide critical health coverage to low income individuals and families Then in 2001 the system grew by acquiring Whidden Hospital in Everett MA and associated health services in Malden and Revere Both efforts allowed the system to continue helping individuals and families in greatest need by improving access to care financially geographically and clinically
New strains of hospital bugs emerging

The HPA report which gives a snapshot of infection rates and antibiotic use last autumn found that while rates of MRSA and Clostridium difficile continue to fall other infections such as E coli and salmonella are taking their place The total prevalence of healthcareassociated infections HCAIs decreased from 82 in 2006 to 64 in 2011 though this h... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More